Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Moderna’s stock doubles on promising cancer-vaccine results

We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at marketwatch.com →

More in Finance & Markets

More from Wednesday 19 August →